AlloVir Inc (ALVR)
AlloVir Market Cap: 89.17M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 89.17M |
May 16, 2024 | 86.41M |
May 15, 2024 | 86.25M |
May 14, 2024 | 88.79M |
May 13, 2024 | 86.26M |
May 10, 2024 | 90.34M |
May 09, 2024 | 93.89M |
May 08, 2024 | 89.91M |
May 07, 2024 | 91.58M |
May 06, 2024 | 92.74M |
May 03, 2024 | 91.70M |
May 02, 2024 | 92.68M |
May 01, 2024 | 93.08M |
April 30, 2024 | 91.29M |
April 29, 2024 | 93.60M |
April 26, 2024 | 91.60M |
April 25, 2024 | 91.93M |
April 24, 2024 | 89.63M |
April 23, 2024 | 90.88M |
April 22, 2024 | 87.68M |
April 19, 2024 | 86.21M |
April 18, 2024 | 85.28M |
April 17, 2024 | 86.98M |
April 16, 2024 | 84.45M |
April 15, 2024 | 85.74M |
Date | Value |
---|---|
April 12, 2024 | 88.10M |
April 11, 2024 | 88.73M |
April 10, 2024 | 86.25M |
April 09, 2024 | 85.46M |
April 08, 2024 | 84.64M |
April 05, 2024 | 85.81M |
April 04, 2024 | 87.29M |
April 03, 2024 | 88.18M |
April 02, 2024 | 88.17M |
April 01, 2024 | 92.46M |
March 28, 2024 | 86.71M |
March 27, 2024 | 87.47M |
March 26, 2024 | 86.15M |
March 25, 2024 | 87.35M |
March 22, 2024 | 86.44M |
March 21, 2024 | 88.55M |
March 20, 2024 | 85.61M |
March 19, 2024 | 85.69M |
March 18, 2024 | 84.07M |
March 15, 2024 | 89.47M |
March 14, 2024 | 83.48M |
March 13, 2024 | 83.67M |
March 12, 2024 | 85.00M |
March 11, 2024 | 83.22M |
March 08, 2024 | 83.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
CEL-SCI Corp | 68.78M |
AIM ImmunoTech Inc | 20.11M |
IGC Pharma Inc | 35.69M |
NovaBay Pharmaceuticals Inc | 4.487M |
Protalix BioTherapeutics Inc | 83.58M |
Market Cap Related Metrics
Price to Book Value | 0.7404 |
Price | 0.7766 |
Earnings Yield | -214.1% |